In 1Q16, LabCorp’s (LH) national clinical laboratory business, LabCorp Diagnostics, accounted for 69.3% of the company’s total revenues. Despite facing the impact of about -0.6% in revenues on a ...
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) reported Q2 CY2025 results , with sales up 9.5% year on year to $3.53 billion. Its non-GAAP profit of $4.35 per share was 4.5% above analysts’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results